0.474 USD
+0.01 (+2.13%)
ChartMill assigns a Buy % Consensus number of 80% to SGMO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.32. This target is 599.37% above the current price.
SGMO was analyzed by 12 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about SGMO.
In the previous month the buy percentage consensus was at a similar level.
SGMO was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-07 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2025-09-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-14 | Barclays | Maintains | Overweight -> Overweight |
| 2025-04-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-18 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2025-01-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-23 | Truist Securities | Maintains | Buy -> Buy |
| 2025-01-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-31 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-12-31 | Jefferies | Maintains | Buy -> Buy |
| 2024-12-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-14 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-10-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-14 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-03-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-02-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-01-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-07 | Truist Securities | Downgrade | Buy -> Hold |
SANGAMO THERAPEUTICS INC / SGMO FAQ
What is the average price target for SANGAMO THERAPEUTICS INC (SGMO) stock?
12 analysts have analysed SGMO and the average price target is 3.32 USD. This implies a price increase of 599.37% is expected in the next year compared to the current price of 0.474.
How do analysts rate SANGAMO THERAPEUTICS INC (SGMO)?
The consensus rating for SANGAMO THERAPEUTICS INC (SGMO) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed SANGAMO THERAPEUTICS INC (SGMO)?
The number of analysts covering SANGAMO THERAPEUTICS INC (SGMO) is 12.